Please login to the form below

Not currently logged in
Email:
Password:

Redx names former Bayer exec as chairman

Frank Armstrong brings decades of experience to infectious disease biotech

Frank Armstrong, RedxRedx Pharma has appointed Dr Frank Armstrong as non-executive chairman.

Dr Armstrong has decades of experience in the pharma industry, including spells as executive VP and head of worldwide product development at Bayer and head of medical science and innovation at Merck Serono.

More recently he has worked as an independent consultant for pharma and biotech companies as well as serving on several company boards and these include current chairman positions at CardioRentis, Summit PLC and Xceleron.

He will now help guide Redx as it advances its research efforts into infectious diseases and cancer.

Dr Peter Jackson, co-founder and director at Redx, said: “[Frank's] pharma business experience and clinical insight will make a valuable contribution to our plans for further growth and he is extremely well networked internationally.”

To date this growth includes the creation of a research centre at AstraZeneca's (AZ) former site in Alderley Park, Cheshire in the UK.

Redx is also working with AZ and this week announced the two companies had signed a collaboration to research the genetic drivers of tumour growth.

4th September 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...